Register to Attend the Webinar:

Global Oncology Opportunities & Trends 2025
Key Markets, Indications and Products
 
Please join Informa Pharma Intelligence and our panel of experts as they discuss the Global Oncology market, examining the key trends and market opportunities available in the Oncology space over the next few years. We will focus on the top-selling products with patents due to expire soon, opening up the market for new generic opportunities, as well as key deals, and clinical pipeline products for potential in/out licensing partnerships. The webinar will also focus on new therapies entering the space, changing the market dynamics and the competitive landscape of the industry.

Session key topics include:

• Patient opportunities and patient-based forecasts
• Top selling drugs with patent expiry due in the next 1 – 4 years
• Late stage opportunities
• Opportunity for novel products
• Key deals (major markets /emerging markets), strategies, disease areas
  
• Likelihood of approval of products in the pipeline
  

Speakers

Poorna Chandra Tejasvi Senior Director- Emerging Markets, India  Poorna now leads the Informa Pharma Intelligence business as Senior Director - Emerging Markets, India and is responsible for new business development in the region for market-leading Pharma Intelligence and Consulting Solutions.                                                                   Poorna has over twenty years of experience covering business development, pharma consulting & international business development in the Pharmaceutical, Generics and Biotech Industry, helping Professionals to make the best decisions from early-stage portfolio decisions, commercial planning to clinical research and development. Prior to joining Informa, Poorna worked as Director - Pharma Segment, South Asia with Clarivate Analytics and Thomson Reuters for over thirteen years, he started the Life Sciences business and built the Sales team in South Asia in 2005 and has grown the business many folds during his tenure. Poorna holds a Master of Business Administration degree from Maharshi University of Management and a Bachelor’s degree in Microbiology from Bangalore University, India.

Anju Ghangurde Executive Editor, APAC   Anju is Executive Editor within the APAC team for Scrip and the Pink Sheet. She has over two decades of experience in journalism including stints at India's leading financial dailies. Based in Mumbai, India, she covers a range of topics across the pharma and biosimilar landscape. Drug pricing, policy and regulatory affairs, M&A and patents are areas of special interest to her. She is also a recipient of the British Chevening Scholarship for Young Indian Journalists (2000-01) awarded by the Foreign & Commonwealth Office. Anju has extensive experience at India's mainstream financial dailies, The Economic Times, The Hindu Business Line and The Financial Express. As Corporate Bureau Chief (Mumbai), she led a team of reporters at The Financial Express prior to joining Scrip. She’s been associated with Scrip since 2001, when it was part of PJB Publications. Anju enjoys covering pharma conferences and interviewing industry heads and regulatory/government officials in the region. Occasionally, she also moderates industry panels at key events.

Vince Spurr Commercial Product Specialist                 Having worked across all of Informa Pharma Intelligence products as a Business Development Manager and Account Manager, Vince’s role is to support clients across the EMEA, India and Mena regions to help understand individual product methodologies and user journeys to maximise the value the Informa solutions can provide.